Global Acellular Therapy Market Size Was Valued at $8.451 Billion in 2022 and Is…
<!-- Name:DistributionId Value:8789732 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Browsing Tag
Acellular
Humacyte Announces Presentations by Ukrainian Surgeons on Use of the Human Acellular…
DURHAM, N.C., Sept. 23, 2022 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable bioengineered human…
Humacyte Announces Presentation on Investigational Human Acellular VesselTM for…
DURHAM, N.C., Sept. 09, 2022 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable bioengineered human…
Humacyte Preclinical Data on Small-Diameter Human Acellular Vessel™ (HAV™) in…
-- Preclinical model data expected to support development of small diameter HAV to treat patients with coronary artery disease-- -- Small-diameter HAV observed to maintain patency and…
Humacyte Announces Preclinical Results of Small-Diameter Human Acellular Vessel™…
-- HAV remained patent and host-cell remodeling was observed in non-human primate model -- -- Preclinical study represents milestone in the development of small-diameter HAVs for use in…